Patents Assigned to The Quigley Corporation
-
Publication number: 20100247685Abstract: A prophylactic treatment for Newcastle disease as well as a treatment of Newcastle disease. The methods comprise the step of administering to a bird, an amount of a composition having a first ingredient obtainable from turmeric; a second ingredient obtainable from green tea; an third ingredient obtainable from ginger; and an acceptable carrier. Compositions in accordance with the invention may be employed for the purpose of reducing the incidence of contracting Newcastle disease or reducing the transmissivity of Newcastle disease.Type: ApplicationFiled: December 14, 2007Publication date: September 30, 2010Applicant: THE QUIGLEY CORPORATIONInventors: Richard Rosenbloom, Timothy Cummings, Michael Petteruti
-
Publication number: 20100028268Abstract: A prophylactic treatment for infectious bronchitis as well as a treatment of infectious bronchitis. The methods comprise the step of administering to a bird, an amount of a composition having a first ingredient obtainable from turmeric; a second ingredient obtainable from green tea; an third ingredient obtainable from ginger; and an acceptable carrier. Compositions in accordance with the invention may be employed for the purpose of reducing the incidence of contracting infectious bronchitis or reducing the transmissivity of infectious bronchitis.Type: ApplicationFiled: December 14, 2007Publication date: February 4, 2010Applicant: THE QUIGLEY CORPORATIONInventors: Richard Rosenbloom, Timothy Cummings, Michael Petteruti
-
Patent number: 7507425Abstract: A method for treatment of cachexia and or alleviating one or more symptoms of cachexia involving the step of administering, to a human or animal, a composition including ingredients obtainable from turmeric, ginger, green tea, and, optionally, horseradish. This composition may further include a pharmaceutically acceptable carrier.Type: GrantFiled: September 26, 2006Date of Patent: March 24, 2009Assignee: The Quigley CorporationInventor: Richard Allen Rosenbloom
-
Publication number: 20080241287Abstract: A method for treatment of cachexia and or alleviating one or more symptoms of cachexia involving the step of administering, to a human or animal, a composition including ingredients obtainable from turmeric, ginger, green tea, and, optionally, horseradish. This composition may further include a pharmaceutically acceptable carrier.Type: ApplicationFiled: September 26, 2006Publication date: October 2, 2008Applicant: THE QUIGLEY CORPORATIONInventor: RICHARD ROSENBLOOM
-
Patent number: 7410659Abstract: Compositions and methods for the treatment of peripheral neural and vascular ailments are disclosed. The method comprises administering a flavonoid compound with antioxidant properties, optionally formulated in a acceptable carrier. This compound or combination of compounds provides significant, effective relief of the symptoms of peripheral neural or vascular ailments. In addition, the compositions, when used according to the methods of the present invention, do not exhibit the severe side effects of many prior art compositions proposed for treatment of these ailments.Type: GrantFiled: June 23, 2005Date of Patent: August 12, 2008Assignee: The Quigley CorporationInventor: Richard A. Rosenbloom
-
Patent number: 7405046Abstract: Methods for prophylactic and anti-transmissivity uses of an anti-microbial composition are disclosed. The methods comprise the step of administering to a mammal or a bird, an amount of a composition having a first ingredient obtainable from ginger; a second ingredient obtainable from green tea; an optional third ingredient obtainable from turmeric; and an acceptable carrier. When administered the composition is effective to reduce the incidence of contracting an illness or to prophylactically prevent transmission of an illness. Also disclosed are nasal and throat spray compositions for use in the methods of the invention.Type: GrantFiled: October 27, 2006Date of Patent: July 29, 2008Assignee: The Quigley CorporationInventor: Richard Allen Rosenbloom
-
Patent number: 7399783Abstract: A topical composition and method for the reduction of scar tissue and/or improving the appearance of scar tissue after it has formed. The topical composition includes one or more flavonoids formulated in a pharmaceutically acceptable topical carrier. The method includes the step of topically applying a composition including one or more flavonoids formulated in a pharmaceutically acceptable topical carrier to scar tissue to reduce the amount of, or improve the appearance of the scar tissue. The topical compositions and methods of the present invention reduce scar tissue after it has formed as well as improving the appearance of the remaining scar tissue.Type: GrantFiled: June 22, 2005Date of Patent: July 15, 2008Assignee: The Quigley CorporationInventor: Richard A. Rosenbloom
-
Patent number: 7396546Abstract: An anti-microbial composition is provided. The anti-microbial composition includes a first ingredient obtainable from ginger, a second ingredient obtainable from green tea, an optional third ingredient available from turmeric, and, optionally, an acceptable carrier. Also provided are methods of reducing, treating or preventing at least one symptom or adverse effect of microbial infection in a patient. The methods include the step of administering to the patient prior to expected exposure to a microbe, concurrently with exposure to a microbe, or after exposure to a microbe, an effective amount of a composition of the invention.Type: GrantFiled: February 6, 2003Date of Patent: July 8, 2008Assignee: The Quigley CorporationInventor: Richard A. Rosenbloom
-
Publication number: 20070104808Abstract: Methods for prophylactic and anti-transmissivity uses of an anti-microbial composition are disclosed. The methods comprise the step of administering to a mammal or a bird, an amount of a composition having a first ingredient obtainable from ginger; a second ingredient obtainable from green tea; an optional third ingredient obtainable from turmeric; and an acceptable carrier. When administered the composition is effective to reduce the incidence of contracting an illness or to prophylactically prevent transmission of an illness. Also disclosed are nasal and throat spray compositions for use in the methods of the invention.Type: ApplicationFiled: October 27, 2006Publication date: May 10, 2007Applicant: THE QUIGLEY CORPORATIONInventor: RICHARD ROSENBLOOM
-
Publication number: 20070071838Abstract: A pharmaceutically acceptable salt of perindopril of formula (I) is made from a protected precursor compound of formula (II) wherein R represents a carboxyl protecting group, which process comprises subjecting a compound of formula (II) to deprotection of the carboxylic group COOR attached to the heterocyclic ring so as to yield the corresponding free acid, which deprotection is carried out in the presence of a base which forms a pharmaceutically acceptable salt with said free acid formed by the deprotection.Type: ApplicationFiled: September 26, 2006Publication date: March 29, 2007Applicant: THE QUIGLEY CORPORATIONInventor: RICHARD ROSENBLOOM
-
Patent number: 7175987Abstract: Prophylactic and treatment methods for treatment of herpes, as well as methods for reducing or preventing the transmission of herpes. The methods comprise the step of administering to a mammal, an amount of a composition having a first ingredient obtainable from ginger; a second ingredient obtainable from green tea; an optional third ingredient obtainable from turmeric; an optional fourth ingredient obtainable from horseradish, and an acceptable carrier. When administered the composition is effective to reduce the incidence of contracting herpes, to reduce or prevent transmission of herpes, to reduce the herpes virus, or to alleviate one or more symptoms of herpes. Also disclosed are suitable formulations for delivery of the compositions for use in the methods of the invention.Type: GrantFiled: March 9, 2006Date of Patent: February 13, 2007Assignee: The Quigley CorporationInventor: Richard A. Rosenbloom
-
Patent number: 7166435Abstract: Methods for prophylactic and anti-transmissivity uses of an anti-microbial composition are disclosed. The methods comprise the step of administering to a mammal or a bird, an amount of a composition having a first ingredient obtainable from ginger; a second ingredient obtainable from green tea; an optional third ingredient obtainable from turmeric; and an acceptable carrier. When administered the composition is effective to reduce the incidence of contracting an illness or to prophylactically prevent transmission of an illness. Also disclosed are nasal and throat spray compositions for use in the methods of the invention.Type: GrantFiled: December 14, 2004Date of Patent: January 23, 2007Assignee: The Quigley CorporationInventor: Richard A. Rosenbloom
-
Patent number: 7083813Abstract: Compositions and methods for the treatment of peripheral neural and vascular ailments are disclosed. The method comprises administering a flavonoid compound with antioxidant properties, optionally formulated in a acceptable carrier. This compound or combination of compounds provides significant, effective relief of the symptoms of peripheral neural or vascular ailments. In addition, the compositions, when used according to the methods of the present invention, do not exhibit the severe side effects of many prior art compositions proposed for treatment of these ailments.Type: GrantFiled: November 6, 2002Date of Patent: August 1, 2006Assignee: The Quigley CorporationInventor: Richard A. Rosenbloom
-
Patent number: 6827945Abstract: A nutritional supplement for providing, and for promoting the health of salivary glands and/or supporting normal or healthy swallowing includes ingredients obtainable from turmeric, ginger, and horseradish. The nutritional supplement may also be used to treat symptoms such as symptoms of a common cold, sore throat, congestion, mucositis, laryngitis, mucous membrane inflammation and sialorrhea, as well as inflammation and viral infectin, or to inhibit or exterminate a virus. This nutritional supplement can be orally administered a person. The nutritional supplement may further include optional ingredients such as ingredients obtainable from slippery elm bark powder and green tea, as well as other optional ingredients. This nutritional supplement may further include a pharmaceutically acceptable carrier for oral administration.Type: GrantFiled: April 23, 2003Date of Patent: December 7, 2004Assignee: The Quigley CorporationInventor: Richard A. Rosenbloom
-
Patent number: 6753325Abstract: A composition for the preventing, reducing or treating radiation dermatitis includes a mixture of one or more compounds that regulates cell differentiation and/or cell proliferation, and one or more antioxidants formulated in a pharmaceutically acceptable carrier. The composition of the present invention may further include a flavonoid. A method for the topical administration of the composition in accordance with the present invention for the purpose of preventing, reducing or treating radiation dermatitis involves topically administering an effective amount of the composition of the invention an area of skin which has been or will be exposed to radiation. The composition and method can be employed to prevent, reduce or treat radiation dermatitis caused by a wide variety of types of radiation exposure and is particularly useful for the prevention, reduction or treatment of radiation recall dermatitis.Type: GrantFiled: November 6, 2001Date of Patent: June 22, 2004Assignee: The Quigley CorporationInventor: Richard Allen Rosenbloom
-
Patent number: 6596313Abstract: A nutritional supplement for promoting the health of salivary glands and supporting the normal or healthy swallowing in a person includes ingredients obtainable from turmeric, ginger, and horseradish. The nutritional supplement may also be used to treat symptoms such as symptoms of a common cold, a sore throat, congestion, mucositis, laryngitis, arthritis, mucous membrane inflammation and sialorrhea is disclosed. This nutritional supplement can be orally administered a person. The nutritional supplement may further include optional ingredients such as ingredients obtainable from slippery elm bark powder and green tea, as well as other optional ingredients. This nutritional supplement may further include a pharmaceutically acceptable carrier for oral administration. A method of promoting the health of salivary glands, supporting the normal or healthy swallowing and/or treating sialorrhea in a person involves administering the nutritional supplement orally to a person one to six times daily, as needed.Type: GrantFiled: April 15, 2002Date of Patent: July 22, 2003Assignee: The Quigley CorporationInventor: Richard A. Rosenbloom
-
Patent number: 6592896Abstract: A novel composition for treating symptoms such as symptoms of a common cold, a sore throat, congestion, laryngitis, mucous membrane inflammation and sialorrhea is disclosed. The composition includes ingredients to obtainable from turmeric extract, ginger root powder, and horseradish root powder. This composition can be orally administered a patient. The composition may further include ingredients obtainable from slippery elm bark powder and green tea. This composition may further include a pharmaceutically acceptable carrier for oral administration. A method of administering this composition orally to a patient to treat symptoms of a common cold, a sore throat, congestion, laryngitis, mucositis, sialorrhea and mucous membrane inflammation is also disclosed. To treat these symptoms, the composition is administered to a patient suffering one to fifteen times daily, as needed. To achieve the best effect, the composition should be held in the mouth of a patient for 5 to 60 minutes.Type: GrantFiled: August 6, 2001Date of Patent: July 15, 2003Assignee: The Quigley CorporationInventor: Richard Allen Rosenbloom
-
Patent number: 6555573Abstract: A method and composition for the treatment of diabetic neuropathy is disclosed. The composition comprises a cold compounded mixture of a compound that promotes synthesis of nerve growth factor, an aldose reductase inhibitor and an antioxidant formulated in a pharmaceutically acceptable carrier. It has been found that this combination of active agents provides significant, effective relief of the symptoms of diabetic neuropathy, as well as at least partial recovery of lost neurological function in some cases. In view of the consensus in the art that effective combinations of various active agents have not been demonstrated to be effective for the treatment of diabetic neuropathy, the present invention provides a surprising and unexpected effect.Type: GrantFiled: December 21, 2000Date of Patent: April 29, 2003Assignee: The Quigley CorporationInventor: Richard Allen Rosenbloom